NCT02296593View on ClinicalTrials.gov

Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

November 30, 2016

Conditions
Other Functional Disturbances Following Cardiac Surgery
Interventions
DEVICE

comparison of blood lactate and glucose levels

comparison of blood lactate and glucose levels with the reference method (co oxymetry) and a new central veinous catheter microdialysis system provided by MAQUET. (Critical Care AB, Solna, Sweden.)

Trial Locations (1)

14000

CHU de Caen, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT02296593 - Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device | Biotech Hunter | Biotech Hunter